phs000872
PsychENCODE Consortium: Autism Post-Mortem Brain RNA-Sequencing - SRRM4 Splicing Study
Purpose: The goal of this study was to assess the status of splicing changes in microexons in the cortex of individuals with autism.  Methods: We performed RiboZero Gold (rRNA depleted) 50bp PE RNA-seq in a larger set of case and control samples to define 12 autism and 12 control samples showing the greatest global differential gene expression change. These samples, which show differential expression of the splicing regulator SRRM4, were used to evaluate global splicing changes.  Results: Within these samples, 126 of 504 (30%) detected alternative microexons display a mean deltaPSI > 10 between ASD and control subjects of which 113 (90%) also display neural-differential regulation. By contrast, only 825 of 15,405 (5.4%) longer (i.e. > 27 nt) exons show such misregulation, of which 285 (35%) correspond to neural-regulated exons. Notably, we also observe significantly higher correlations between microexon inclusion and nSR100 mRNA expression levels across the... (for more see dbGaP study page.)